Skip to main content
251 results

The Coronavirus pandemic has created a challenging environment for the delivery of care to patients with respiratory disease.

On World Lung Day, 25 September 2022, the Forum of International Respiratory Societies (FIRS) calls on governments worldwide to address stark global inequalities in respiratory health.

PCRS joins the nation in offering our sincere and heartfelt condolences to the Royal Family on the death of Her Majesty the Queen.

The PCRS conference is one of the highlights of the PCRS calendar. This year, we are excited to be bringing back our regular face-to-face conference and we’ll be travelling down to Telford International Centre on 22nd September spring in our step!

After nearly three years in the role, Lynn Ladbrook, PCRS CEO, has announced that she will be leaving the Primary Care Respiratory Society at the end of September to take on a new role at the Association of Science Education.

Supply disruption of varenicline has been on going since October 2021 because of the presence of nitrosamines above acceptable level of daily intake. There is still no certainty when varenicline will return.

A new ‘NICE real-world evidence framework’ was launched last week, with the aim to improve the quality of real-world evidence which informs NICE guidance development.

During 2021, IPCRG has been providing evidence based answers to the questions our global Sentinel Network of practising primary health care professionals ask about COVID.

Pre-emptively identifying patients with asthma most at risk for exacerbation and intervening to improve their asthma control has the potential to save lives.

Asking patients with respiratory disease about their use of candles and whether they have an attached garage may not be at the top of the list when conducting a regular reviews but perhaps it should be.

There are currently around 1.3 million people in the UK who have been diagnosed with COPD. It is a condition that affects the quality of life of those affected and can lead to premature death.

The PCRS Greener Respiratory Healthcare Pathway is the latest in a suite of tools available to support colleagues working in primary care to understand and deliver greener and more sustainable high quality respiratory healthcare that is kinder to environment.

PCRS is deeply concerned about the takeover of Vectura, a pharmaceutical company producing medicines for the treatment of respiratory disease, by Philip Morris International, a company whose tobacco products continue to cause addiction, suffering and death around the world.